Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1996 Dec;89(12):679–680. doi: 10.1177/014107689608901206

Endogenous neurotoxins relevant to schizophrenia.

J Smythies 1
PMCID: PMC1296029  PMID: 9014877

Full text

PDF
679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aroca P., Solano F., Salinas C., García-Borrón J. C., Lozano J. A. Regulation of the final phase of mammalian melanogenesis. The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole. Eur J Biochem. 1992 Aug 15;208(1):155–163. doi: 10.1111/j.1432-1033.1992.tb17169.x. [DOI] [PubMed] [Google Scholar]
  2. Carstam R., Brinck C., Hindemith-Augustsson A., Rorsman H., Rosengren E. The neuromelanin of the human substantia nigra. Biochim Biophys Acta. 1991 Sep 23;1097(2):152–160. doi: 10.1016/0925-4439(91)90100-n. [DOI] [PubMed] [Google Scholar]
  3. Enochs W. S., Sarna T., Zecca L., Riley P. A., Swartz H. M. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J Neural Transm Park Dis Dement Sect. 1994;7(2):83–100. doi: 10.1007/BF02260963. [DOI] [PubMed] [Google Scholar]
  4. Filloux F., Townsend J. J. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol. 1993 Jan;119(1):79–88. doi: 10.1006/exnr.1993.1008. [DOI] [PubMed] [Google Scholar]
  5. GEIGER R. S. Effects of LSD-25, serotonin and sera from schizophrenic patients on adult mammalian brain cultures. J Neuropsychiatr. 1960 Apr;1:185–199. [PubMed] [Google Scholar]
  6. GROF S., VOJTECHOVSKY M., VITEK V., PRANKOVA S. CLINICAL AND EXPERIMENTAL STUDY OF CENTRAL EFFECTS OF ADRENOCHROME. J Neuropsychiatr. 1963 Oct;4:33–50. [PubMed] [Google Scholar]
  7. Goodwin F., Shafritz D., Weissbach H. In vitro polypeptide synthesis in brain. Arch Biochem Biophys. 1969 Mar;130(1):183–190. doi: 10.1016/0003-9861(69)90024-1. [DOI] [PubMed] [Google Scholar]
  8. Graham D. G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol. 1978 Jul;14(4):633–643. [PubMed] [Google Scholar]
  9. HOFFER A., OSMOND H., SMYTHIES J. Schizophrenia; a new approach. II. Result of a year's research. J Ment Sci. 1954 Jan;100(418):29–45. doi: 10.1192/bjp.100.418.29. [DOI] [PubMed] [Google Scholar]
  10. Hastings T. G. Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem. 1995 Feb;64(2):919–924. doi: 10.1046/j.1471-4159.1995.64020919.x. [DOI] [PubMed] [Google Scholar]
  11. Kelsoe J. R., Jr, Tolbert L. C., Crews E. L., Smythies J. R. Kinetic evidence for decreased methionine adenosyltransferase activity in erythrocytes from schizophrenics. J Neurosci Res. 1982;8(1):99–103. doi: 10.1002/jnr.490080113. [DOI] [PubMed] [Google Scholar]
  12. Mattammal M. B., Strong R., Lakshmi V. M., Chung H. D., Stephenson A. H. Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease. J Neurochem. 1995 Apr;64(4):1645–1654. doi: 10.1046/j.1471-4159.1995.64041645.x. [DOI] [PubMed] [Google Scholar]
  13. Pileblad E., Slivka A., Bratvold D., Cohen G. Studies on the autoxidation of dopamine: interaction with ascorbate. Arch Biochem Biophys. 1988 Jun;263(2):447–452. doi: 10.1016/0003-9861(88)90657-1. [DOI] [PubMed] [Google Scholar]
  14. RINKEL M., SOLOMON H. C. Chemical theories of psychosis. J Clin Exp Psychopathol. 1957 Oct-Dec;18(4):323–334. [PubMed] [Google Scholar]
  15. SCHWARZ B. E., SEM-JACOBSEN C. W., PETERSEN M. C. Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man. AMA Arch Neurol Psychiatry. 1956 Jun;75(6):579–587. doi: 10.1001/archneurpsyc.1956.02330240017002. [DOI] [PubMed] [Google Scholar]
  16. Sargent T., 3rd, Kusubov N., Taylor S. E., Budinger T. F. Tracer kinetic evidence for abnormal methyl metabolism in schizophrenia. Biol Psychiatry. 1992 Dec 15;32(12):1078–1090. doi: 10.1016/0006-3223(92)90188-6. [DOI] [PubMed] [Google Scholar]
  17. Shafritz D., Goodwin F., Weissbach H. Inhibition by aminochromes of in vitro polypeptide synthesis in Escherichia coli. Arch Biochem Biophys. 1969 Nov;134(2):478–485. doi: 10.1016/0003-9861(69)90308-7. [DOI] [PubMed] [Google Scholar]
  18. Smit N. P., Pavel S., Kammeyer A., Westerhof W. Determination of catechol O-methyltransferase activity in relation to melanin metabolism using high-performance liquid chromatography with fluorimetric detection. Anal Biochem. 1990 Nov 1;190(2):286–291. doi: 10.1016/0003-2697(90)90195-f. [DOI] [PubMed] [Google Scholar]
  19. Taborsky R. G. Indoxyl derivatives: potential psychotropic metabolites. Int J Neuropharmacol. 1968 Nov;7(6):483–486. doi: 10.1016/0028-3908(68)90058-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES